视频资源-国产精品午夜自在在线精品,国产揄拍国产精品视频,最新国产无码片,av免费无码在线观看

EN
CNEN

LDEBIO's AIMTB (Chemiluminescence Method) Secures National Class III Medical Device Certification, Completing Full-Platform, Full-Scenario TB Detection Solutions to Boost Global TB Control

Release date:2024-09-12Views: TimesInformation Sources: Leide Biosciences Co., Ltd.

September 12, 2024 – LDEBIO is pleased to announce that its innovative tuberculosis (TB) infection detection product, the AIMTB Mycobacterium Tuberculosis-Specific Cellular Immune Response Detection Kit (Chemiluminescence Method), has successfully obtained the Class III Medical Device Registration Certificate from the National Medical Products Administration (NMPA). This achievement follows the recent certification of the AIMTB (Fluorescence Immunochromatography Method) in early September, further solidifying LDEBIO 's leadership in TB detection technology and marking the completion of its full-platform,full-scenario product portfolio for TB infection detection.

Official WeChat
Service hotline:
+86 20 82113921

Add:7D, Science & Technology Innovation Base, #80 Lanyue Road, Huangpu District, Guangzhou, P.R.China